VRDN Shares Outstanding History — Viridian Therapeutics Share Count Over Time

As of 5/1/2026 Viridian Therapeutics has 103.07 million VRDN shares outstanding. Investors often track the VRDN shares outstanding history to compare shareholder return trends against the change in share count over time.

This page shows VRDN share count trends over time, with 22 historical shares outstanding datapoints presented, dating back to 11/13/2020.

Quick links: Shares Outstanding History Table  |  Shares Outstanding History Chart  |  About Viridian Therapeutics
VRDN Shares Outstanding History



Below is a table of the VRDN shares outstanding history going back to 11/13/2020:

Date VRDN Shares Outstanding
11/13/20203.91M
3/18/20217.23M
5/4/20218.43M
8/10/20219.59M
11/3/202121.72M
3/7/202225.91M
5/9/202227.93M
8/10/202228.46M
11/9/202240.25M
3/3/202342.90M
5/5/202343.13M
8/7/202343.67M
11/7/202352.59M
2/22/202462.77M
5/1/202463.82M
8/5/202463.89M
11/7/202479.21M
5/1/202581.59M
8/1/202581.66M
10/31/202595.44M
2/20/2026102.21M
5/1/2026103.07M

Also see: VRDN Market Cap History
VRDN YTD Return
VRDN Historical Shares Outstanding:
+82.01% CAGR
VRDN Historical Shares Outstanding: +82.01% CAGR

Mouse over chart for data details
11/13/2020 ...5/1/2026
Viridian Therapeutics, Inc. is a biopharmaceutical company focused on engineering and developing potential medicines for patients with serious and rare diseases. Co. is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). Co. is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. It is focused on advancing VRDN-001 as a potential intravenous therapy followed by VRDN-003 as a potential subcutaneous therapy for the treatment of TED. We show 22 historical shares outstanding datapoints in our coverage of VRDN's shares outstanding history.

Understanding the changing numbers of VRDN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VRDN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VRDN by allowing them to research VRDN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree VRDN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance
Viridian Therapeutics (VRDN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

VREX Shares Outstanding History
VRML Shares Outstanding History
VRPX Shares Outstanding History
VRTX Shares Outstanding History
VRX Shares Outstanding History
VSAR Shares Outstanding History
VSTM Shares Outstanding History
VTGN Shares Outstanding History
VTL Shares Outstanding History
VTRS Shares Outstanding History
More Healthcare companies »
 

VRDN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.